key opinion leaders

By Sarah Ray, Research Analyst Drug companies are reaching beyond specialists when targeting medical leaders to further develop their existing products.  Among 36 companies recently surveyed, nearly four-fifths targeted multiple types of key opinion...

When France first released its 2011 draft of the Bertrand Act — which included a provision similar to the Sunshine Act here in the US – the legislation promised to be more stringent than US guidelines.  The draft required companies to post its payments on...

As with any industry team, medical science liaisons (MSLs) must convince their bosses that the department — and their jobs — is worth the effort and funding that go into it. For MSL teams, however, convincing upper management and key stakeholders is only half...

Sales teams and medical science liaisons (MSLs) might be seen as having distinct objectives, but in reality the two groups can work well together for the benefit of the company.  ‘Synergies’ might have become an overused and clichéd business mantra, but in...

The simple answer to this question is yes. Pharma has already produced a plethora of mobile and digital devices geared to both patient and physician perspectives. With the accessibility of these versatile apps, pharma’s targets continue to demand more. While...

As the old saying goes, "Good help is hard to find." Well, sometimes the best option is to make it easier for the help to find you. Our research has shown that Investigator-Initiated Trial proposals are on the rise over the last three years — averaging 173.3...

Significant changes to medical science liaisons’ roles and expectations in the past 15 years have underscored the value MSLs bring to their organizations. MSLs not only provide access to highly influential physicians and medical researchers, but they also bring...

By Elio Evangelista, Director of Research As two of the major roles of medical science liaisons (MSLs), identifying influential physicians and building relationships with those thought leaders occupy more time than other activities. The actual amount...

By Stephanie Swanson, Strategic Marketing Manager The CEI research team is launching two new benchmarking studies that will explore the value proposition, Return-on-Investment and performance measurement of the Medical Science Liaison function. Early...

Cutting Edge Information's new customizable "MSL Data Suite" combines the company's experience in researching medical science liaison performance and MSL program management with our team's strength in providing Life Science companies with benchmarking data, analysis...